Lidewij S Boogers, Chantal M Wiepjes, Annemieke S Staphorsius, Daniel T Klink, Silvia Ciancia, Alessia Romani, Tessa H R Stolk, Emmy van den Boogaard, Thomas D Steensma, Annelou L C de Vries, A S Paul van Trotsenburg, Martin den Heijer, Alessandra D Fisher, Martine Cools, Sabine E Hannema
BACKGROUND: Knowledge regarding the effects and side effects of gender-affirming hormone therapy (GAHT) in adults is rapidly growing, partly through international research networks such as the European Network for the Investigation of Gender Incongruence (ENIGI). However, data on the effects of puberty suppression (PS) and GAHT in transgender and gender diverse (TGD) youth are limited, although these data are of crucial importance, given the controversies surrounding this treatment. AIM: We sought to present a detailed overview of the design of the ENIGI Adolescents study protocol, including the first baseline data...
March 1, 2024: Journal of Sexual Medicine